Showing results (1701-1710 of 1,881) with videos related to
Sort By:
Pageof 189
Immunotherapy|May 29, 2019
Toxicity patterns associated with chemotherapy/immune checkpoint inhibitor combinations: a meta-analysisOmar Abdel-RahmanImmunotherapy|September 24, 2021
Clinical predictors of chimeric antigen receptor T-cell therapy neurotoxicity: a single-center studyCarlen Yuen, Kourosh Rezania, Thomas Kelly, et al.Immunotherapy|February 7, 2022
Subcutaneous immunoglobulin use in immunoglobulin-naive patients with primary immunodeficiency: a systematic reviewColin Anderson-Smits, Michelle Park, Judith Bell, et al.Immunotherapy|October 21, 2021
Body composition and inflammation impact in non-small-cell lung cancer patients treated by first-line immunotherapyCinzia Baldessari, Annarita Pecchi, Raffaella Marcheselli, et al.Immunotherapy|March 21, 2022
Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatmentHenrry Diaz Londres, Jorge Jiménez Armada, Aray Hernández Martínez, et al.Immunotherapy|April 4, 2022
PD-1/L1 inhibitors may increase the risk of pericardial disease in non-small-cell lung cancer patients: a meta-analysis and systematic reviewHonglin Li, Deting Han, Lei Zhang, et al.Immunotherapy|April 5, 2022
Immune checkpoint inhibitor-induced neurologic toxicity: a case report and literature reviewValeria Emma Palmieri, Giandomenico Roviello, Martina Catalano, et al.Immunotherapy|April 6, 2022
The emerging role of immunotherapy in biliary tract cancer: a review of new evidence and predictive biomarkersRoberta Giorgione, Matteo Risaliti, Ilenia Bartolini, et al.Immunotherapy|September 7, 2018
Novel immunotherapy strategies for hepatobiliary cancersThomas T DeLeon, Yumei Zhou, Bolni M Nagalo, et al.Pageof 189